Revian Strengthens Scientific Expertise with Dr. Jordan R. Plews as Advisor

Revian Appoints Dr. Jordan R. Plews as Scientific Advisor

Revian Inc., a pioneering company in medical technology known for its innovative light therapies aimed at rejuvenating hair and skin, has recently appointed Dr. Jordan R. Plews as its Scientific Advisor. This strategic move is indicative of Revian’s ambition to enhance its clinically-focused initiatives and strengthen its innovative capacities.

Dr. Plews comes with a wealth of knowledge and experience in biotechnology, regenerative medicine, and medical aesthetics, aligning perfectly with Revian's mission of integrating scientific principles into cutting-edge medical applications. With a background as a stem cell scientist and biochemical engineer, he is well-positioned to help bridge the gap between scientific research and practical clinical use.

John Oakley, the CEO of Revian, expressed his enthusiasm regarding Dr. Plews' appointment. He noted that Dr. Plews possesses a unique mix of profound scientific knowledge, real-world application experience, and industry insight, making him an invaluable addition to the team. Oakley emphasized that Dr. Plews' contributions will significantly aid in enhancing physician education, improving clinical engagement, and fostering effective scientific communication as Revian continues to expand its footprint in the medical technology landscape.

In his new role, Dr. Plews will focus on broadening Revian’s educational programs while also assisting in the ongoing refinement and development of its technology platforms. He is deeply committed to translating complex scientific concepts into actionable insights that yield tangible results, rooted in solid evidence rather than mere marketing claims.

Dr. Plews is also not new to the global stage; he is an active participant in forums discussing regenerative medicine and medical aesthetics. He is scheduled to deliver a presentation titled "Regenerative Aesthetics Exosomes, Secretomes, and Beyond!" during a CME session at The Aesthetic Show on June 25, 2026. Further, on June 26, he will contribute to a panel discussion on innovations related to hair restoration treatments. These engagements will enable Dr. Plews to share insights on the latest developments in regenerative aesthetics, emphasizing evidence-based strategies to support skin and hair health.

About Revian, Inc.

Revian, functioning as a subsidiary of KNOW Bio, LLC, stands at the forefront of medical technology innovation dedicated to natural skincare and rejuvenation. Utilizing patented therapies, Revian aims to harness the body’s innate processes to enhance hair and skin vitality. The company is firmly rooted in science, backing its products with rigorous data and proven clinical outcomes, providing at-home treatments that cater to men and women affected by hair thinning. Revian is committed to forging partnerships with healthcare professionals, all while striving to deliver meaningful, safer, and innovative solutions in the wellness sector. For further details about Revian and its offerings, visit www.revian.com.